Skip to main content
Caplight Logo









AMILI

AMILI

Private
SingaporeHealthcare & Life Scienceshttps://amili.asia/

Last Round

Series A

Extension

May 29, 2023

Total Funding Raised

$10.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

AMILI is a biotechnology company that provides gut microbiome data insights, analytics, tests, and therapeutics, and operates Southeast Asia's first gut microbiome transplant bank.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

gut microbiome testingprecision nutritionmicrobiome databioinformaticsmicrobiome sequencinggut healthpersonalized healthAI nutritionbiobankFMTfecal microbiota transplantclinical diagnosticshealth-techat-home testingbiohacker

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMILI Comparables

Compare AMILI with similar companies based on industry and business-model similarity.

AMILI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GenieBiome
81%
Leucine Rich Bio
81%
Biome Diagnostics
77%

AMILI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 29, 2023
Series AJun 15, 2022

Key People

Founding team and executive leadership

Jeremy Lim

Chief Executive Officer

Executive Team

Manu Swarup

Chief Operating Officer

Executive Team

AMILI Investors

Notable investors and investment history

AMILI investors
InvestorRounds
G. K. Goh Holdings Pte. Ltd.Series A
Capital CodeSeries A
SEEDS CapitalSeries A
Blue7Series A
Vulcan CapitalSeries A
East VenturesSeries A Extension
Elang Mahkota TeknologiSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 192% MoM, reaching 39.2K.

  • Jul 26, 2026

    Monthly visitors grew 119% MoM, from 6.1K to 13.4K.

AMILI Filings

Explore SEC and related filing metadata, where available.

AMILI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AMILI's valuation, stock price, and market status.

Is AMILI a public or private company?

AMILI is a private company.

What is the current stock price of AMILI?

AMILI is a private company with no public stock price. No recent secondary market data is available.

How much is AMILI worth (valuation)?

Valuation information for AMILI is not publicly available.

Can I buy AMILI stock?

AMILI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AMILI's last funding round?

AMILI's most recent funding round was Debt on May 29, 2023.

Who are the main investors in AMILI?

Key investors in AMILI include East Ventures, Cercano Management.

Will AMILI IPO soon?

No public IPO plans have been announced for AMILI.

How can I track AMILI secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AMILI's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range61
Year Founded2019
Last FundingMay 29, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?